Association between antibiotic use and neonatal mortality and morbidities in very low-birth-weight infants without culture-proven sepsis or necrotizing enterocolitis

JAMA Pediatrics

Volumn 170, Issue 12, 2016, Pages 1181-1187

  Ting, Joseph Y ^a   Synnes, Anne ^a   Roberts, Ashley ^a   Deshpandey, Akhil ^b   Dow, Kimberly ^c   Yoon, Eugene W ^d   Lee, Kyong Soon ^d,e   Dobson, Simon ^a   Lee, Shoo K ^d,e   Shah, Prakesh S ^d,e  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Janeway Children's Health and Rehabilitation Centre   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADVERSE OUTCOME; ARTICLE; BACTERIUM CULTURE; BRAIN VENTRICLE; CANADA; CHRONIC LUNG DISEASE; CLINICAL EVALUATION; COHORT ANALYSIS; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DRUG USE; FEMALE; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NECROTIZING ENTEROCOLITIS; NEONATAL INTENSIVE CARE UNIT; NEUROIMAGING; NEWBORN MORBIDITY; NEWBORN MORTALITY; ODDS RATIO; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; SEPSIS; TREATMENT DURATION; VERY LOW BIRTH WEIGHT; CLINICAL TRIAL; INFANT MORTALITY; INTENSIVE CARE; MORBIDITY; MORTALITY; MULTICENTER STUDY; NEWBORN; PERINATAL CARE; STATISTICS AND NUMERICAL DATA;

ANTI-BACTERIAL AGENTS; CANADA; CRITICAL CARE; ENTEROCOLITIS, NECROTIZING; FEMALE; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE UNITS, NEONATAL; LENGTH OF STAY; MALE; MORBIDITY; PERINATAL CARE; RETROSPECTIVE STUDIES; SEPSIS;

EID: 85011340542     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2016.2132     Document Type: Article

References (42)

1. Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics. 2006;117(6):1979-1987.
2. Fanaroff AA, Korones SB,Wright LL, et al; National Institute of Child Health and Human Development Neonatal Research Network. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. Pediatr Infect Dis J. 1998;17(7): 593-598.
3. Cantey JB, Patel SJ. Antimicrobial stewardship in the NICU. Infect Dis Clin NorthAm. 2014;28(2):247-261.
4. Engle WD, Jackson GL, Sendelbach D, et al. Neonatal pneumonia: comparison of 4 vs 7 days of antibiotic therapy in term and near-term infants. J Perinatol. 2000;20(7):421-426.
5. Wójkowska-Mach J, Ró?a?ska A, Borszewska-KornackaM, et al. Necrotising enterocolitis in preterm infants: epidemiology and antibiotic consumption in the Polish Neonatology Network neonatal intensive care units in 2009. PLoS One. 2014;9(3):e92865. doi:10.1371/journal .pone.0092865
6. Cotten CM. Antibiotic stewardship: reassessment of guidelines for management of neonatal sepsis. Clin Perinatol. 2015;42(1):195-206, x.
7. Bizzarro MJ, Gallagher PG. Antibiotic-resistant organisms in the neonatal intensive care unit. Semin Perinatol. 2007;31(1):26-32.
8. Saiman L. Risk factors for hospital-acquired infections in the neonatal intensive care unit. Semin Perinatol. 2002;26(5):315-321.
9. Saiman L, Ludington E, Dawson JD, et al; National Epidemiology ofMycoses Study Group. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J. 2001;20(12):1119-1124.
10. Kuppala VS, Meinzen-Derr J, Morrow AL, Schibler KR. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr. 2011;159(5):720-725.
11. Cotten CM, Taylor S, Stoll B, et al; NICHD Neonatal Research Network. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics. 2009;123(1):58-66.
12. Cotten CM, McDonald S, Stoll B, Goldberg RN, Poole K, Benjamin DK Jr; National Institute for Child Health and Human Development Neonatal Research Network. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics. 2006;118(2):717-722.
13. Neu J, Douglas-Escobar M, Lopez M. Microbes and the developing gastrointestinal tract. Nutr Clin Pract. 2007;22(2):174-182.
14. Douglas-Escobar M, Elliott E, Neu J. Effect of intestinal microbial ecology on the developing brain. JAMA Pediatr. 2013;167(4):374-379.
15. Canadian Neonatal Network. Abstractor's manual. http://www.canadianneonatalnetwork.org /Portal/LinkClick.aspx?fileticket=U4anCYsSN20 %3D&tabid=69. Published September 19, 2011. Accessed September 15, 2016.
16. Kramer MS, Platt RW,Wen SW, et al; Fetal/Infant Health Study Group of the Canadian Perinatal Surveillance System. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics. 2001;108(2):E35.
17. Richardson DK, Corcoran JD, Escobar GJ, Lee SK. SNAP-II and SNAPPE-II: simplified newborn illness severity and mortality risk scores. J Pediatr. 2001;138(1):92-100.
18. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg. 1978;187(1):1-7.
19. Kwon SH, Vasung L, Ment LR, Huppi PS. The role of neuroimaging in predicting neurodevelopmental outcomes of preterm neonates. Clin Perinatol. 2014;41(1):257-283.
20. Jasani B, Nanavati R, Kabra N. Mechanisms and management of retinopathy of prematurity. N Engl J Med. 2013;368(12):1161-1162.
21. Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med. 2007;357(19): 1946-1955.
22. Lee SK, Shah PS, Singhal N, et al; Canadian EPIQ Study Group. Association of a quality improvement program with neonatal outcomes in extremely preterm infants: a prospective cohort study. CMAJ. 2014;186(13):E485-E494. doi:10.1503/cmaj.140399
23. Schulman J, Dimand RJ, Lee HC, Duenas GV, Bennett MV, Gould JB. Neonatal intensive care unit antibiotic use. Pediatrics. 2015;135(5):826-833.
24. Cordero L, Ayers LW. Duration of empiric antibiotics for suspected early-onset sepsis in extremely low birth weight infants. Infect Control Hosp Epidemiol. 2003;24(9):662-666.
25. Spitzer AR, Kirkby S, Kornhauser M. Practice variation in suspected neonatal sepsis: a costly problem in neonatal intensive care. J Perinatol. 2005;25(4):265-269.
26. Patel SJ,Oshodi A, Prasad P, et al. Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12-Step Campaign to Prevent Antimicrobial Resistance. Pediatr Infect Dis J. 2009;28(12):1047-1051.
27. Flenady V, Hawley G, Stock OM, Kenyon S, Badawi N. Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database Syst Rev. 2013;12(12):CD000246.
28. Ng PC, Ma TP, Lam HS. The use of laboratory biomarkers for surveillance, diagnosis and prediction of clinical outcomes in neonatal sepsis and necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed. 2015;100(5):F448-F452.
29. Connell TG, Rele M, Cowley D, Buttery JP, Curtis N. How reliable is a negative blood culture result? volume of blood submitted for culture in routine practice in a children's hospital. Pediatrics. 2007;119(5):891-896.
30. Schelonka RL, Chai MK, Yoder BA, Hensley D, Brockett RM, Ascher DP. Volume of blood required to detect common neonatal pathogens. J Pediatr. 1996;129(2):275-278.
31. Verani JR,McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1-36.
32. Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics. 2006;117(1):67-74.
33. Faa G, Gerosa C, Fanni D, Nemolato S, van Eyken P, Fanos V. Factors influencing the development of a personal tailored microbiota in the neonate, with particular emphasis on antibiotic therapy. J Matern Fetal Neonatal Med. 2013;26(suppl 2):35-43.
34. Schumann A, Nutten S, Donnicola D, et al. Neonatal antibiotic treatment alters gastrointestinal tract developmental gene expression and intestinal barrier transcriptome. Physiol Genomics. 2005;23(2):235-245.
35. Fouhy F, Guinane CM, Hussey S, et al. High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother. 2012;56(11): 5811-5820.
36. Arboleya S, Sánchez B, Milani C, et al. Intestinal microbiota development in preterm neonates and effect of perinatal antibiotics. J Pediatr. 2015;166 (3):538-544.
37. Goldstein EJ. Beyond the target pathogen: ecological effects of the hospital formulary. Curr Opin Infect Dis. 2011;24(suppl 1):S21-S31.
38. Singh N, Patel KM, Léger MM, et al. Risk of resistant infections with Enterobacteriaceae in hospitalized neonates. Pediatr Infect Dis J. 2002;21 (11):1029-1033.
39. Lee JH, Hornik CP, Benjamin DK Jr, et al. Risk factors for invasive candidiasis in infants >1500 g birthweight. Pediatr Infect Dis J. 2013;32(3):222-226.
40. de Man P, Verhoeven BA, Verbrugh HA, Vos MC, van den Anker JN. An antibiotic policy to prevent emergence of resistant bacilli. Lancet. 2000;355(9208):973-978.
41. Arshad M, Seed PC. Urinary tract infections in the infant. Clin Perinatol. 2015;42(1):17-28, vii.
42. Pramanik AK, Rangaswamy N, Gates T. Neonatal respiratory distress: a practical approach to its diagnosis and management. Pediatr Clin North Am. 2015;62(2):453-469.